Patrick Troy is a Respiratory physician affiliated with Ascension. OpenAlex indexes 27 publications with 649 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
85 Seymour St
Suite 923
Hartford, CT 061065501
Telephone
860-524-4550Provider last certified this registry record 1 Apr 2021.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202552 payments$57,328openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202519 payments
- GlaxoSmithKline, LLC.Program year202533 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
80.4%Corticosteroid48.5%Trelegy Ellipta67%Breo Ellipta19%Fluticasone Propionate8%Budesonide-Formoterol Fumarate7%Part D<11 patientsbeta2-Adrenergic Agonist13.5%Albuterol Sulfate Hfa100%Part D≥20 patients+ 3 more classes in this area
Nervous system
14.3%gamma-Aminobutyric Acid A Receptor Positive Modulator6.1%Zolpidem Tartrate100%Part D<11 patientsCentrally acting sympathomimetics4.8%Armodafinil100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.3%Corticosteroid5.3%Prednisone100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The enigma of fine mobile structures on the aortic surface in a patient undergoing transcatheter aortic valve replacement: a case report
European Heart Journal - Case Reports
2024 - Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE)
Journal of the Society for Cardiovascular Angiography & Interventions
2023 - Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects
Journal of Antimicrobial Chemotherapy
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Frederick Masoudi, MD
Ascension
Thomas Aloia, MD
Ascension
Douglas Reding, MD
Ascension
Stacey Ishman, MD
Ascension
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”